A significant reduction of opioid use in patients after colorectal surgery was supported by clinician and patient compliance, ...

Beyond administering CAR T-cell therapy and bispecifics, oncology nurses must apply proactive, supportive care and an understanding of complex treatments.

Neurotoxicities can be monitored long term with personalized questions, according to Mary Steinbach, DNP, APRN.

The NCCN has added zongertinib to its guidelines for the care of patients with HER2 (ERBB2)-mutated non–small cell lung cancer.

BC, AOCNP, explained that adverse effects are common among the available antibody-drug conjugates in breast cancer.

In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...

Oncology nurses play a key role in monitoring, managing, and personalizing CDK4/6 inhibitor treatment to minimize toxicities ...

Barriers to CAR T-cell therapy exist for patients with multiple myeloma, even in urban areas, said Mary Steinbach, DNP, APRN, ...

Panelists discuss how they monitor and educate patients on ALK inhibitor side effects while equipping nursing staff to manage toxicities proactively.

This educational session on ALK-positive non-small cell lung cancer (NSCLC) explores how the treatment landscape has evolved due to biomarker-driven therapies and the integration of multidisciplinary ...

Panelists discuss how evolving clinical advances and biomarker-driven therapies have transformed treatment practices and outcomes for patients with ALK+ NSCLC.